Monday, July 17, 2017

Peptide complex in the brain is responsible for Alzheimer's disease

Members of the Faculty of Fundamental Medicine at the Lomonosov Moscow State University have determined the structure of a peptide complex formed in the brain at the early stages of Alzheimer’s disease. The research results will contribute to the rational design of compounds to block the progress of the disease.

from Dementia Big http://ift.tt/2uzrS5K via alcoholic dementia


http://ift.tt/2uzDpSH

Hearing is believing: Speech may be a clue to mental decline

Your speech may, um, help reveal if you’re uh … developing thinking problems. More pauses, filler words and other verbal changes might be an early sign of mental decline, which can lead to Alzheimer’s disease, a study suggests.

from Dementia Big http://ift.tt/2v96Tnu via alcoholic dementia


http://ift.tt/2v8FNwT

Combining care program with drug reduces damaging effects of Alzheimer's disease

Combining a specific care management program with a commonly-prescribed drug for Alzheimer’s disease multiplies the medication’s ability to improve daily function by about 7.5 times, stalling some of the disease’s most damaging effects.

from Dementia Big http://ift.tt/2thYsJg via alcoholic dementia


http://ift.tt/2uA62z0

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models

Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance.

from Dementia Big http://ift.tt/2tZQsLw via alcoholic dementia


http://ift.tt/2v9cx9b

Peptide complex in the brain is responsible for Alzheimer's disease

Peptide complex in the brain is responsible for Alzheimer's disease:

Dementia Big
Members of the Faculty of Fundamental Medicine at the Lomonosov Moscow State University have determined the structure of a peptide complex formed in the brain at the early stages of Alzheimer’s disease. The research results will contribute to the rational design of compounds to block the progress of the disease.


http://ift.tt/2uzDpCb

Combining care program with drug reduces damaging effects of Alzheimer's disease

Combining care program with drug reduces damaging effects of Alzheimer's disease:

Dementia Big
Combining a specific care management program with a commonly-prescribed drug for Alzheimer’s disease multiplies the medication’s ability to improve daily function by about 7.5 times, stalling some of the disease’s most damaging effects.


http://ift.tt/2v91sVs

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models

Inhibition of cell receptors clears toxic proteins, cuts inflammation and improves cognition in animal models:

Dementia Big
Researchers have found cell receptors abnormally overexpressed in post-mortem brains of those with Parkinson’s and Alzheimer’s diseases, and that they can be inhibited in animal models to clear toxic protein buildup, reduce brain inflammation, and improve cognitive performance.


http://ift.tt/2uzUWKj